1. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Issue 10075 (25th March 2017) Authors: Cameron, David; Piccart-Gebhart, Martine J; Gelber, Richard D; Procter, Marion; Goldhirsch, Aron; de Azambuja, Evandro; Castro, Gilberto; Untch, Michael; Smith, Ian; Gianni, Luca; Baselga, Jose; Al-Sakaff, Nedal; Lauer, Sabine; McFadden, Eleanor; Leyland-Jones, Brian; Bell, Richard; Dowsett, Mitc... Journal: Lancet Issue: Volume 389:Issue 10075(2017) Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378). (January 2016) Authors: Tryfonidis, Konstantinos; Basaran, Gul; Bogaerts, Jan; Debled, Marc; Dirix, Luc; Thery, Jean-Christophe; Tjan-Heijnen, Vivianne C.G.; Van den Weyngaert, Danielle; Cufer, Tanja; Piccart, Martine; Cameron, David Journal: European journal of cancer Issue: Volume 53(2016) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Life of Learning and Other Pleasures: John Meisel's TaleByJohnMeisel. Yarker, Ontario: Wintergreen Studios Press, 2012. Pp. 403. (March 2014) Authors: Cameron, David Journal: Canadian public administration Issue: Volume 57:Number 1(2014:Mar.) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies. (12th March 2021) Authors: Dahlenburg, Heather; Cameron, David; Yang, Sheng; Bachman, Angelica; Pollock, Kari; Cary, Whitney; Pham, Missy; Hendrix, Kyle; White, Jeannine; Nelson, Haley; Deng, Peter; Anderson, Joseph S.; Fink, Kyle; Nolta, Jan Journal: Stem cells translational medicine Issue: Volume 10:Number 7(2021) Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Novel Huntington's Disease Mouse Model to Assess the Role of Neuroinflammation on Disease Progression and to Develop Human Cell Therapies. (12th March 2021) Authors: Dahlenburg, Heather; Cameron, David; Yang, Sheng; Bachman, Angelica; Pollock, Kari; Cary, Whitney; Pham, Missy; Hendrix, Kyle; White, Jeannine; Nelson, Haley; Deng, Peter; Anderson, Joseph S.; Fink, Kyle; Nolta, Jan Journal: Stem cells translational medicine Issue: Volume 10:Number 7(2021) Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized controlled trial of a brief online intervention to reduce alcohol consumption in new university students: Combining self‐affirmation, theory of planned behaviour messages, and implementation intentions. Issue 1 (20th September 2017) Authors: Norman, Paul; Cameron, David; Epton, Tracy; Webb, Thomas L.; Harris, Peter R.; Millings, Abigail; Sheeran, Paschal Journal: British journal of health psychology Issue: Volume 23:Issue 1(2018) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A ROS-integrated API for the KUKA LBR iiwa collaborative robot*. Issue 1 (July 2017) Authors: Mokaram, Saeid; Aitken, Jonathan M.; Martinez-Hernandez, Uriel; Eimontaite, Iveta; Cameron, David; Rolph, Joe; Gwilt, Ian; McAree, Owen; Law, James Journal: IFAC-PapersOnLine Issue: Volume 50:Issue 1(2017) Page Start: 15859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A theory-based online health behaviour intervention for new university students (U@Uni:LifeGuide): results from a repeat randomized controlled trial. Issue 1 (December 2015) Authors: Cameron, David; Epton, Tracy; Norman, Paul; Sheeran, Paschal; Harris, Peter; Webb, Thomas; Julious, Steven; Brennan, Alan; Thomas, Chloe; Petroczi, Andrea; Naughton, Declan; Shah, Iltaf Journal: Trials Issue: Volume 16:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. Issue 7 (July 2017) Authors: Cameron, David; Morden, James P; Canney, Peter; Velikova, Galina; Coleman, Robert; Bartlett, John; Agrawal, Rajiv; Banerji, Jane; Bertelli, Gianfilippo; Bloomfield, David; Brunt, A Murray; Earl, Helena; Ellis, Paul; Gaunt, Claire; Gillman, Alexa; Hearfield, Nicholas; Laing, Robert; Murray, Nichol... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial. Issue 6 (June 2017) Authors: Earl, Helena M; Hiller, Louise; Howard, Helen C; Dunn, Janet A; Young, Jennie; Bowden, Sarah J; McDermaid, Michelle; Waterhouse, Anna K; Wilson, Gregory; Agrawal, Rajiv; O'Reilly, Susan; Bowman, Angela; Ritchie, Diana M; Goodman, Andrew; Hickish, Tamas; McAdam, Karen; Cameron, David; Dodwell, Dav... Journal: Lancet oncology Issue: Volume 18:Issue 6(2017:Jun.) Page Start: 755 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗